Europe Россия Внешние малые острова США Китай Объединённые Арабские Эмираты Корея Индия

Belgian Deputy PM says a European Action Plan on Rare Diseases is ‘essential’

5 months ago 24

By Euractiv’s Health Hub

Belgium is supporting the creation of a European action plan for rare diseases and is joining other EU member states adopting a national plan, Belgium’s Deputy Prime Minister and Minister of Health and Social Affairs, Frank Vandenbroucke, said.

Vandenbroucke spoke at the Rare Diseases Forum in Brussels, which called for a European plan similar to ‘Europe’s Beating Cancer Plan’.

With data showing the EU lagging behind the US and China in research and innovation expenditure, venture capital investment, and the number of clinical trials taking place in Europe, speakers raised concern about Europe’s ability to compete.

There are obvious benefits of scale by taking a more ambitious European-level approach. Rare diseases impact fewer than five in every 10,000 people. Cumulatively, there are more than 30 million people across Europe living with a rare disease. 

The European Parliament also enthusiastically supports more European action to tackle the problem. Last week it adopted an amendment to the pharmaceutical package calling for a dedicated framework for rare diseases to bridge legislation, policies and programmes, with a view to better meeting the needs of people living with rare diseases. 

Yann Le Cam, the outgoing chief executive officer at Rare Diseases Europe (EURORDIS), said Europe needs competitiveness, attractiveness, and a strong ecosystem: “What matters is size, volume and investment.” 

“We need to develop our efforts financially and we need strong coordination,” said Le Cam. “We need to exploit synergies between research and healthcare with a strategy on data that is empowering that collaboration.”

Fifth Freedom

In Enrico Letta’s final report on the “future of the EU’s single market”, obtained by Euractiv and expected to be presented to EU leaders on Thursday morning, healthcare is identified as a sector that “stands out prominently”. The report states that European healthcare urgently requires significant revitalization and improved resilience.  

Letta is calling for a ‘fifth freedom’ in addition to the EU’s four freedoms (people, goods, services and capital) to embed research and innovation as drivers of the single market.

A central pillar of his proposal is the creation of a European Knowledge Commons – a digital platform pooling publicly funded research, data sets and educational resources. Letta argues that bold new goals will mobilise political will, innovation and strategic investment.

———————————————————————————————————-

Today’s edition is powered by VivaTech

Discover the future of healthcare at VivaTech, Europe’s biggest startup and tech event, from May 22 to 25 in Paris!

Explore the most disruptive topics in tech, discover the latest healthcare innovations, and find out how trends and patterns are helping patients at VivaTech.

Book your pass now on vivatech.com

—————————————————————————————————–

  • UK’s radical bill on Tobacco and Vapes likely to become law. The UK parliament endorsed the Tobacco and Vapes Bill on Tuesday (16 April), which sets the ambitious target of the UK achieving smoke-free status by 2030, a decade ahead of the EU target. Catherine Feore reported.
  • European Commission registers European Citizens’ Initiative to support safe and accessible abortion. Wednesday (10 April) the European Commission registered a European Citizens’ Initiative (ECI) for safe and accessible abortion. The decision paves the way for the ‘My Voice, My Choice’ movement to collect the required one million signatures for their cause. Catherine Feore reported.
  • Pharma Package adopted at first reading with landslide vote, but what next? After the European Parliament adopted the Pharma Package by a landslide vote at first reading on Wednesday (10 April), it is now at the mercy of the Council and the next Commission – assuming there is a new one in the next six months – and a new Parliament. So what next? Catherine Feore reported.
  • MEPs want to include abortion in EU Charter of Fundamental Rights. The European Parliament voted in favour of enshrining the right to abortion in the Charter of Fundamental Rights of the European Union on Thursday (11 April), but its chances of succeeding are slim as it would require the green light from all 27 member states. Clara Bauer-Babef reported.
  • French government introduces assisted dying bill. The French government introduced the bill on assisted dying on Wednesday (10 April), and Labour and Health Minister Catherine Vautrin outlined the details of the future law that will allow terminal patients suffering from long-term illnesses to decide to end their life. Clara Bauer-Babef reported.
  • Germany should modernise abortion law, commission says. Access to abortion in Germany falls short of international human rights standards and public health guidelines, according to a report published by a government-appointed commission on Monday (15 April). “German law on abortion stigmatises women who seek abortion care and demeans their ability to make autonomous and informed decisions about their pregnancies”, agreed the Center for Reproductive Rights (CRR) in a press release. Therefore, the commission’s experts have recommended several changes, like legalising abortion during the first twelve weeks. Even though they are rarely punished, abortions are illegal in Germany, except in certain cases like if a woman is a victim of rape, or if her life is at risk. By Clara Bauer-Babef.

News from the capitals

ATHENS
Greek Prime Minister, Kyriakos Mitsotakis, says he wants Greece to attract more investment from global pharmaceutical companies, to foster life science innovation, while promoting discussions related to European competitiveness. Read more.

///

STOCKHOLM
Sweden aims to keep current data protection period in EU pharma package.
 The Swedish government is opposed to shortening the regulatory data protection period (RDP) for new medicines, as currently proposed by the EU Commission in its pharma legislative overhaul. Swedish key stakeholders are demanding a stronger focus on patients and healthcare. Read more.

Sweden’s NATO membership a challenge for Swedes’ struggling health system.
NATO’s Secretary-General, Jens Stoltenberg, says Sweden needs to increase its health capacity to respond to a crisis or war. As NATO-focused plans are prepared, cutbacks and a lack of healthcare staff could limit national preparedness. Read more.

///

PRAGUE
Czechia lacks a vaccination strategy, pharma package could bring focus says MP.
 Czechia has no clearly defined vaccination strategy, but a new impetus for change could come from the new EU pharmaceutical package, Czech MP tells Euractiv. Read more.

///

DUBLIN
Ireland’s pharmaceutical industry launches innovation-focused EU election manifesto. 
Ireland’s pharmaceutical innovators have unveiled their European election manifesto in the Irish Midlands-Northwest constituency. With candidates present, the IPHA said they stand ready to work with European health leaders to enable faster and fairer access to life-enhancing medicines. Read more.

///

BRUSSELS
Belgium’s university-industry collaboration model could accelerate EU’s advanced therapeutics. 
Despite its significant potential, Europe trails North America and the Asian Pacific in Advanced Therapy Medicinal Product (ATMP) development, clinical trials, and investment. Belgium however, boasts one of the highest densities of advanced therapy companies globally. Read more.

Pharma package revisions embed a European solidarity mechanism, says Belgian MEP Ries. Patients with rare diseases will be clear beneficiaries of the European Parliament’s vote on the revised pharmaceutical legislation, says Belgian MEP Frédérique Ries. The pharma package revisions will also embed a European solidarity mechanism, capitalising on European added value. Read more.

///

WARSAW
Poland’s emergency contraception bill standoff following Duda veto. 
Poland’s emergency contraception bill ignites tense constitutional standoff, following the Polish health ministry’s response to President Duda’s veto. Read more.

On the agenda

24 April: Belgian Presidency launch of the Critical Medicines Alliance.

22 – 25 April, European Parliament plenary: Final votes on the so-called “SoHO” – substances of human origin regulation and the European Health Data Space and the revision to the Ambient Air Quality Directives.

21–27 April: The WHO European Region celebrates European Immunization Week (EIW) to promote awareness of the importance of immunization in preventing diseases and protecting life. This year marks the 50th anniversary of the Expanded Programme on Immunization (EPI). Over five decades EPI has protected millions of people from serious vaccine-preventable illnesses.

[Edited by Zoran Radosavljevic]

Read more with Euractiv

Read Entire Article